Gustaf Duhs

Apr 30, 2024 | stevens-bolton.com | Gustaf Duhs |Jeremy Kelly |Jessica Gregson

The use of artificial intelligence (AI) in the life sciences sector is increasing, and its applications may be transformative. AI is currently used with drug discovery, diagnostics, clinical care, health systems management and planning, public health surveillance, and disease control and prevention, as well as in general business applications, such as HR or accounting.

Apr 30, 2024 | lexology.com | Gustaf Duhs |Jeremy Kelly |Jessica Gregson

The use of artificial intelligence (AI) in the life sciences sector is increasing, and its applications may be transformative. AI is currently used with drug discovery, diagnostics, clinical care, health systems management and planning, public health surveillance, and disease control and prevention, as well as in general business applications, such as HR or accounting.

Mar 1, 2024 | lexology.com | Gustaf Duhs

The recent conviction of Elizabeth Holmes in relation to fraudulent activities at biotech company Theranos reminds us of the impact that whistleblowing has had in the life sciences sector. Dr Li Wenliang’s attempts to raise the alarm in relation to COVID-19 in 2019 is another high-profile example. But what are the legal issues arising from whistleblowing? Of course, these can be viewed from both the individual whistleblower’s and the business’ perspective.

Feb 5, 2024 | lexology.com | Gustaf Duhs

The relationship between the pharmaceutical industry, healthcare professionals and healthcare organisations plays a vital role in the development of medicines. However, there is also increased industry as well as general public demand for clearer and objective reporting on the research, clinical trial/testing, distribution and advertising practices involved in bringing pharmaceutical products to the market and administering treatments.

Aug 9, 2023 | lexology.com | Gustaf Duhs

The UK government has had significant issues with the implementation the UK’s post-Brexit products safety conformity mark, the UKCA mark, with ever lengthening deadlines until it is required across all sectors. Now the UK government has announced that it intends to extend the recognition of the European product safety conformity marking, the so-called CE mark, "indefinitely beyond December 2024" in respect of the 18 regulations that fall under the remit of the Department for Business and Trade.